NPCE vs SCHW · rev $22.8M vs P/E 19, rev $13.55B
Neuropace Inc (NPCE) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Walt Bettinger.
Latest reported NPCE revenue for 2026-06-30 was $22.8M. Net income was -$6.2M. Revenue was up 3.4% from 2026-03-31 to 2026-06-30. NPCE currently screens at market cap $312.2M.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
NPCE currently screens at market cap $312.2M. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the NPCE and SCHW stock pages for the full models.
Not investment advice.